Anti-hypertensive sulfonanilides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564 99, 424451, 424464, A61K 3118, C07C31113

Patent

active

051944502

ABSTRACT:
The present invention is concerned with compounds of formula (I) ##STR1## wherein R.sup.1 is hydrogen or C.sub.1-4 alkoxy;

REFERENCES:
patent: 4044150 (1977-08-01), Kriegbaum et al.
patent: 4473586 (1984-09-01), Debernardis et al.
J. Org. Chem., 1985, 50 pp. 5446-5448, "Diisopinocampheylchloroborane. A Remarkably Efficient Third Reducing Agent, etc." Chandrasekhaan et al.
Aldrichimica Ata, vol. 20, No. 1, 1987, I. Chiral Reducing Agents.
Schliken et al, J. of Cardiovascular Pharmacology, 6, pp. 1238-1244, 1984; "Increased Affinity and Preference of Halogenated Derivatives of BE 2254, etc."
Temple et al., J. of Med. Chem., 1976, vol. 19, No. 5, Adrencrgic Sulfonanilides. 4. Centrally Active .beta.-Adrenergic Agonists.
Repke et al., J. of Pharmaceutical Sciences, vol. 74, No. 1, Jun. 1985, "Synthesis and Hypotensive Properties of Substituted 2-Amino Tetraline".
Singh et al., Drugs, 34:311-349 (1987) "Sotalol, A. Review, etc."

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-hypertensive sulfonanilides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-hypertensive sulfonanilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hypertensive sulfonanilides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-350775

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.